Comparison of the Cecum Ligation and Puncture Method and the Intraperitoneal Lipopolysaccharide Injection Method for the Construction of a New-Onset Atrial Fibrillation Model of Sepsis
Xiuwen Ling,Jun Shen,Junqing Liang,Kai Yang,Jianzhong Yang
DOI: https://doi.org/10.2147/jir.s485142
IF: 4.5
2024-11-27
Journal of Inflammation Research
Abstract:Xiuwen Ling, 1, &ast Jun Shen, 2, &ast Junqing Liang, 2 Kai Yang, 1 Jianzhong Yang 1 1 Emergency & Trauma Center, The First Affiliated Hospital of Xinjiang Medical University, Xinjiang, People's Republic of China; 2 Cardiac Pacing and Electrophysiology Department, The First Affiliated Hospital of Xinjiang Medical University, Urumqi, Xinjiang, People's Republic of China &astThese authors contributed equally to this work Correspondence: Jianzhong Yang, Emergency & Trauma Center, The First Affiliated Hospital of Xinjiang Medical University, Urumqi, Xinjiang, 830011, People's Republic of China, Tel/Fax +86 18040399020, Email Background: New-onset atrial fibrillation (AF) in sepsis significantly impacted patient morbidity and mortality, yet the optimal animal model for studying this condition remains undetermined. This study aimed to establish a stable animal model for new-onset AF in sepsis and to explore the molecular mechanisms involved. Methods: Forty-seven Sprague-Dawley rats were utilized, with the cecal ligation and puncture (CLP) group divided into 0.6 mm and 1.0 mm needle outer diameter subgroups, and the lipopolysaccharide (LPS) group into 5 mg/kg, 10 mg/kg, 15 mg/kg, and 20 mg/kg dosage subgroups. The incidence of new-onset AF and five-day mortality rates were compared to identify the most stable modeling conditions. Selected subgroups underwent further analysis, including cardiac ultrasound, electrophysiology, and pathological examinations. Inflammation-related molecular levels in the atrium were assessed using ELISA and Western blotting (WB). Results: The intraperitoneal injection of 10 mg/kg LPS was identified as the most stable model for new-onset AF in sepsis, with significant findings including increased left atrial area and fibrosis, left ventricular pump dysfunction, uncoordinated ventricular wall motion, and impaired electrical impulse conduction. The effective atrial refractory period was markedly shorter, and susceptibility to AF was higher in the LPS group compared to the CLP group. Molecular analysis revealed elevated levels of NOD-like receptor protein 3(NLRP3) inflammasomes, apoptosis-associated speck-like protein containing a CARD(ASC), Caspase-1 p20 Elevated levels of three inflammation-related proteins and increased activity of the Sphingosine 1-phosphate/Sphingosine 1-phosphate Receptor 2(S1P/S1P2) signaling axis. Conclusion: Intraperitoneal injection of 10 mg/kg of LPS can successfully construct a new-onset AF model in sepsis, and NLRP3 inflammatory vesicles mediated by the S1P/S1P2 signaling axis may promote new-onset AF in sepsis. Keywords: sepsis, atrial fibrillation, rat model, lipopolysaccharide, NLRP3 inflammasome, S1P/S1P2 signaling axis Sepsis was a critical systemic inflammatory response syndrome triggered by infection. 1,2 It was frequently associated with cardiac arrhythmias, particularly AF, which was the most prevalent arrhythmia in this context. 3 AF that arises during sepsis and was not present beforehand is termed new-onset AF in sepsis. 4 Patients who develop new-onset AF during sepsis exhibited a significantly elevated five-year risk of hospitalization for heart failure compared to those without AF. 5 Moreover, survivors of sepsis with new-onset AF were prone to recurrent AF post-discharge and face increased long-term risks of in-hospital mortality, post-discharge mortality, heart failure, ischemic stroke, and overall mortality. 6,7 The pathophysiological mechanisms underlying new-onset AF in sepsis were not well understood and may be distinct from those of AF in non-septic contexts. The development of stable animal models for sepsis-induced new-onset AF was challenging. Current approaches involved creating models through genetic engineering to induce spontaneous AF or by electrically stimulating the left atrium to provoke AF, with large animals such as horses, pigs, and dogs being the typical subjects. 8–10 However, the complexity and expense of these methods hindered high-throughput experimental research into the pathogenesis and treatment of sepsis-induced AF. The primary sepsis models currently in use include CLP and intraperitoneal injection of LPS. 5 The severity of sepsis in CLP models has been categorized, with approximately two-thirds cecum ligation representing a model for severe sepsis, 11 which means that this modeling modality has the highest level of inflammation and may be better suited to explore the relationship between inflammation and new-onset atrial fibrillation. Both CLP and LPS models in mice and rats have demonstrated the occurrence of arrhythmias in sepsis, -Abstract Truncated-
immunology